BeStock  
Stocks › Biotechnology › DNTH

Dianthus Therapeutics DNTH

US equityMarket cap rank #2087Biotechnology
$84.55 −$0.28 (-0.33%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $84.08 -0.56%
Open$83.62
Prev close$84.83
Day range$82.53 – $85.67
Volume799.7K
Market cap$4.76B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-22.5x
CheapRich

Near the bottom of its 5-year range · 6th percentile, 5-year average -7.2x

Price / book4.2x
CheapRich

Near the top of its 5-year range · 85th percentile, 5-year average 1.9x

#4180 of 5331 stocks by PB (1 = cheapest)

Price / sales1,902.2x
CheapRich

Near the top of its 5-year range · 87th percentile, 5-year average 517.1x

#5105 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-29x-18x-8x3xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$113.44
Price vs. fair value-25.5%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 4.16 – 1.91 85% (pricier than usual) #4180 of 5331 (1 = cheapest)
PE -22.50 -21.65 -7.21 6% (cheaper than usual) –
PS 1,902.16 3,186.88 517.12 87% (pricier than usual) #5105 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on DNTH.

Sign in to join the discussion.

Scroll to Top